GLYRX-PF

NDC 51754-6015 · Exela Pharma Sciences, LLC

Generic nameglycopyrrolate

Dosage formINJECTION, SOLUTION

RouteINTRAMUSCULAR, INTRAVENOUS

Active ingredient(s)GLYCOPYRROLATE

Strength.2 mg/mL

Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]

Marketing categoryNDA

Packages

51754-6015-3 — 10 SYRINGE, PLASTIC in 1 CARTON (51754-6015-3) / 5 mL in 1 SYRINGE, PLASTIC

Billed under HCPCS

J1597 — Injection, glycopyrrolate (glyrx-pf), 0.1 mg Medicare Part B payment limit (ASP + 6%): $1.32

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51662-1425 — GLYCOPYRROLATE, 51662-1431 — GLYCOPYRROLATE, 51662-1484 — GLYCOPYRROLATE, 51662-1487 — GLYCOPYRROLATE, 51662-1554 — GLYCOPYRROLATE, 51662-1601 — GLYCOPYRROLATE, 51672-5316 — Glycopyrrolate Oral Solution, 51754-6000 — glycopyrrolate, 51754-6001 — glycopyrrolate, 51754-6013 — glycopyrrolate, 55111-648 — Glycopyrrolate, 55111-649 — Glycopyrrolate, 55150-292 — Glycopyrrolate, 55150-293 — Glycopyrrolate, 55150-294 — Glycopyrrolate, 55150-295 — Glycopyrrolate, 55154-7475 — Glycopyrrolate, 59651-435 — GLYCOPYRROLATE, 60429-666 — GLYCOPYRROLATE, 60687-458 — GLYCOPYRROLATE, +177 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.